Integrin indecision

Nature Medicine

Volumn 8, Issue 1, 2002, Pages 14-16

  Carmeliet, Peter ^a  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BETA3 INTEGRIN; BETA5 INTEGRIN; ENDOSTATIN; GELATINASE A; INTEGRIN; THROMBOSPONDIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTHRITIS; CANCER; CONTROLLED STUDY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETINA ISCHEMIA; SHORT SURVEY;

ANIMALS; ANTIGENS, CD; ENDOTHELIUM, VASCULAR; INTEGRIN ALPHAV; INTEGRIN BETA CHAINS; INTEGRIN BETA3; INTEGRINS; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PATHOLOGIC; PLATELET MEMBRANE GLYCOPROTEINS;

ANIMALIA;

EID: 0036156813     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0102-14     Document Type: Short Survey

References (11)

1. Cell adhesion: Old and new questions
2. Integrin signaling
3. Adhesion events in angiogenesis
4. Integrins in vascular development
5. Angiogenesis in cancer and other diseases
6. 5 integrins
7. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
8. Mechanisms of angiogenesis and arteriogenesis
9. Functional consequences of integrin gene mutations in mice
10. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
11. Trans-dominant inhibition of integrin function